Table 2.
Height Z-scores of 99 children treated for different types of nephrotic syndrome.
| Frequency % | Male % | Mean age (yr) | Follow up duration | PDN cumulative dose (mg) | Primary Ht Zb |
Current Ht Z |
ΔHt Zc | Predicted Ht Z | |
|---|---|---|---|---|---|---|---|---|---|
| SSNS | 63.6 | 74.6 | 6.74 (2.5)a |
2.24 (1.87) |
272 (136) |
−0.17 (1.33) |
−0.42 (0.99) |
−0.2 (0.99) |
0.6 (1.24) |
| SDNS | 25.3 | 60 | 7.52 (2.1) |
4.19 (1.95) |
757 (503) |
−0.7 (1.1) |
−0.44 (0.96) |
0.33 (1.36) |
0.7 (1.7) |
| SRNS | 11.1 | 54 | 6.5 (2.4) |
3.4 (1.38) |
793 (405) |
−0.4 (1.26) |
−1.59 (1.34) |
−1.1 (1.31) |
0.03 (0.6) |
| All cases | 100 | 68.7 | 6.9 (2.42) |
2.87 (2.02) |
452 (385) |
−0.3 (1.28) |
−0.5 (1.07) |
−0.18 (1.17) |
−0.3 (1.39) |
SSNS, steroid-sensitive nephrotic syndrome; sDNS, steroid-dependent nephrotic syndrome; SRNS, steroid-resistant nephrotic syndrome.
a
Values in parenthesis indicate the standard deviation.
b
Height Z-score.
c
Δ; Z-score post-treatment − primary Z-score.